Previous Close | 51.99 |
1-Year Change | 22.73% |
6-Months Change | 23.7% |
3-Months Change | 16.83% |
Moving Avg (50d) | 50.602 |
Moving Avg (200d) | 45.508 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.655B |
Beta (3-Years) | 0.99 |
Revenue Growth (ttm) | 25.17% |
Net Profit Margin (ttm) | 25.93% |
Return On Assets (ttm) | 18.68% |
EPS (ttm) | 1.3 |
PE Ratio (ttm) | 39.99 |
Dividend Yield | 2.02% |
Asset Description: | IRadimed Corporation |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
54.295 | 55.891 | 56.956 | 58.553 | 61.214 | 63.876 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.